Reflections and Roadmaps: Career Development beyond the FDA-AACR Oncology Educational Fellowship.
expert_opinion · Level V
Where this comes from
- Record sourced from PubMed, PMID 38856702.
- Also identified by DOI 10.1158/1078-0432.CCR-24-1444.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
In 2020, the FDA's Oncology Center of Excellence, in collaboration with the American Association for Cancer Research, launched a novel educational partnership known as the FDA-AACR Oncology Educational Fellowship. This year-long program is aimed for hematology/oncology fellows, scientists, and early-career investigators, offering an in-depth exploration of the regulatory review process by blending didactic learning with practical cases discussing oncology drug approvals. The fellowship has been met with enthusiastic feedback, with participants lauding its role in demystifying the regulatory landscape and enhancing their professional careers. This article reflects on the experiences of four alumni, showcasing the program's transformative impact across diverse oncology career paths in government, academia, and industry.
Medical subject headings
- Fellowships and Scholarships
- United States Food and Drug Administration
- Medical Oncology